(Q54326192)

27 May 2018

title

Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer. (English)

1 reference

27 May 2018

peritoneal carcinomatosis

main subject

1 reference

7

Yasushi Yatabe

1 reference

27 May 2018

author name string

Takuya Saito

1

1 reference

27 May 2018

Hayao Nakanishi

2

1 reference

27 May 2018

Yoshinari Mochizuki

3

1 reference

27 May 2018

Seiji Ito

4

1 reference

27 May 2018

Yuichi Ito

5

1 reference

27 May 2018

Kazunari Misawa

6

1 reference

27 May 2018

Keigo Yamamichi

8

1 reference

27 May 2018

Eisaku Kondo

9

1 reference

27 May 2018

publication date

31 August 2014

1 reference

27 May 2018

published in

Gastric Cancer

1 reference

27 May 2018

volume

18

1 reference

27 May 2018

issue

4

1 reference

27 May 2018

page(s)

711-719

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s10120-014-0417-4

exact match

0 references

cites work

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Chemotherapy for metastatic gastric cancer: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Bright-field HER2 dual in situ hybridization (DISH) assay vs fluorescence in situ hybridization (FISH): focused study of immunohistochemical 2+ cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Delay to formalin fixation effect on breast biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10120-014-0417-4

HER2 expression and its clinicopathological features in resectable gastric cancer

21 January 2018

1 reference

12 December 2020

Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).

1 reference

12 December 2020

Evaluation of HER2 protein expression in gastric carcinomas: comparative analysis of 1,414 cases of whole-tissue sections and 595 cases of tissue microarrays

1 reference

12 December 2020

HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review

1 reference

12 December 2020

Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection

1 reference

12 December 2020

Lapatinib sensitivities of two novel trastuzumab-resistant HER2 gene-amplified gastric cancer cell lines

1 reference

12 December 2020

Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system

1 reference

12 December 2020

Intratumoral heterogeneous amplification of ERBB2 and subclonal genetic diversity in gastric cancers revealed by multiple ligation-dependent probe amplification and fluorescence in situ hybridization.

1 reference

12 December 2020

10.1007/S10120-014-0417-4

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018